Osimertinib 417716-92-8 It enables the isolation of

It enables the isolation of two sub-Golgi fractions: the Golgi apparatus and secretory vesicles of the Golgi

Adezmapimod does not disrupt JNK activity and is an autophagy and mitophagy activator

AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0

the microtubule (MT) building block

Native plasma membranes are separated from a mixture of unruptured cells

Osimertinib 417716-92-8 It enables the isolation ofOsimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R T790M, respectively. Osimertinib overcomes T790M mediated resistance to EGFR inhibitors in lung cancer.